Profile
David N.
Standring worked as an Associate Director in the Virology Department at Schering-Plough Research Institute from 1998 to 2000.
He then worked as the Chief Scientific Officer and Executive VP at Idenix Pharmaceuticals LLC from 2000 to 2013.
Standring holds a doctorate degree from Harvard University and a graduate degree from the University of Oxford.
Former positions of David N. Standring
| Companies | Position | End |
|---|---|---|
| IDENIX PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 08/09/2013 |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | 30/06/2000 |
Training of David N. Standring
| Harvard University | Doctorate Degree |
| University of Oxford | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Health Technology |
- Stock Market
- Insiders
- David N. Standring
